No photo of Lisa O'Connor
  • United Kingdom

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Lisa O'Connor is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
beta-Lactams Medicine & Life Sciences
Multiple Drug Resistance Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Computer Simulation Medicine & Life Sciences
Methylation Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences

Research Output 2010 2011

9 Citations (Scopus)

In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer

Murphy, T., Sullivan, L., Lane, C., O'Connor, L., Barrett, C., Hollywood, D., Lynch, T., Lawler, M., Perry, A. S. & Lawler, M., 01 Jan 2011, In : Prostate. 71, 1, p. 1-17 17 p.

Research output: Contribution to journalArticle

Computer Simulation
Prostatic Neoplasms
High Pressure Liquid Chromatography
21 Citations (Scopus)

The vascular targeting agent combretastatin-A4 and a novel cis-Restricted {beta}-Lactam Analogue, CA-432, induce apoptosis in human chronic myeloid leukemia cells and ex vivo patient samples including those displaying multidrug resistance

Greene, L. M., Nathwani, S. M., Bright, S. A., Fayne, D., Croke, A., Gagliardi, M., McElligott, A. M., O'Connor, L., Carr, M., Keely, N. O., O'Boyle, N. M., Carroll, P., Sarkadi, B., Conneally, E., Lloyd, D. G., Lawler, M., Meegan, M. J., Zisterer, D. M. & Lawler, M., Nov 2010, In : The Journal of pharmacology and experimental therapeutics. 335, 2, p. 302-13 12 p.

Research output: Contribution to journalArticle

Multiple Drug Resistance
Myeloid Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Blood Vessels